Judge Won't Block FDA's Generic Abilify Approvals
Otsuka Pharmaceutical Co. Ltd. won't be able to keep generic versions of its antipsychotic drug Abilify off the shelves, a Maryland federal judge said Wednesday, holding that the U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article